Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis


Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge

Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations

for Veterans and the Public

Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations


For the full PDF version, click here


This revision (July 28, 2015) incorporates preferred regimens for chronic hepatitis C virus (HCV) genotypes 1 and 4, and extension to 16 weeks of treatment for HCV genotype 2 with cirrhosis. Additional revisions include updates on principles of patient identification, evaluation, and treatment; laboratory monitoring; drug use in renal insufficiency; and drug-drug interactions to provide clinicians with guidance on the concomitant use of HCV drugs and other drugs including HIV antiretroviral agents (Appendix, Tables 4 and 5). The Panel continues to recommend that HIV/HCV-coinfected patients receive the same HCV antiviral regimen as HCV-monoinfected patients.